| Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer |
| WL McGuire |
|
JCO Jul 1 1988: 1071–1072.
[PDF]
|
 |
| Diagnostic factors in intermediate and high-grade lymphomas: pathologic, immunologic, and clinical |
| PA Bunn, Jr |
|
JCO Jul 1 1988: 1073–1075.
[PDF]
|
|
|
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06 |
| |
B Fisher, C Redmond, ER Fisher, and R Caplan |
| |
JCO Jul 1 1988: 1076–1087.
[Abstract]
[PDF]
|
|
|
Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia |
| |
M Shimoyama, K Ota, M Kikuchi, K Yunoki, S Konda, K Takatsuki, M Ichimaru, S Tominaga, S Tsugane, and K Minato |
| |
JCO Jul 1 1988: 1088–1097.
[Abstract]
[PDF]
|
|
|
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association |
| |
HB Muss, HB Wells, EH Paschold, WR Black, MR Cooper, RL Capizzi, R Christian, JM Cruz, DV Jackson, and BL Powell |
| |
JCO Jul 1 1988: 1098–1106.
[Abstract]
[PDF]
|
|
|
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy |
| |
B Fowble, R Gray, K Gilchrist, RL Goodman, S Taylor, and DC Tormey |
| |
JCO Jul 1 1988: 1107–1117.
[Abstract]
[PDF]
|
|
|
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma |
| |
T Philip, O Hartmann, P Biron, JY Cahn, F Pein, P Bordigoni, G Souillet, M Gartner, C Lasset, and F Chauvin |
| |
JCO Jul 1 1988: 1118–1124.
[Abstract]
[PDF]
|
|
|
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome |
| |
AF List, JP Greer, JC Cousar, RS Stein, DH Johnson, VH Reynolds, FA Greco, JM Flexner, and KR Hande |
| |
JCO Jul 1 1988: 1125–1133.
[Abstract]
[PDF]
|
|
|
Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five- drug regimen including etoposide |
| |
D Kalwinsky, J Mirro, Jr, M Schell, F Behm, C Mason, and GV Dahl |
| |
JCO Jul 1 1988: 1134–1143.
[Abstract]
[PDF]
|
|
|
Significance of pulmonary computed tomography at diagnosis in Wilms' tumor |
| |
JA Wilimas, EC Douglass, HL Magill, S Fitch, and HO Hustu |
| |
JCO Jul 1 1988: 1144–1146.
[Abstract]
[PDF]
|
|
|
An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer |
| |
J Ensley, J Kish, E Tapazoglou, J Jacobs, A Weaver, D Atkinson, K Ahmed, R Mathog, and M Al-Sarraf |
| |
JCO Jul 1 1988: 1147–1153.
[Abstract]
[PDF]
|
|
|
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow- up |
| |
JA Levi, D Thomson, T Sandeman, M Tattersall, D Raghavan, M Byrne, G Gill, V Harvey, I Burns, and R Snyder |
| |
JCO Jul 1 1988: 1154–1160.
[Abstract]
[PDF]
|
|
|
Improvement of long-term survival in extensive small-cell lung cancer |
| |
DV Jackson, Jr, LD Case, PJ Zekan, BL Powell, RD Caldwell, JD Bearden, EC Nelson, HB Muss, MR Cooper, and F Richards, 2d |
| |
JCO Jul 1 1988: 1161–1169.
[Abstract]
[PDF]
|
|
|
Effects of interleukin-2 immunotherapy on renal function |
| |
GA Kozeny, JD Nicolas, S Creekmore, L Sticklin, JE Hano, and RI Fisher |
| |
JCO Jul 1 1988: 1170–1176.
[Abstract]
[PDF]
|
|
|
Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up |
| |
DE Hallahan, ML Griem, SF Griem, M Medenica, K Soltani, AL Lorincz, and JM Baron |
| |
JCO Jul 1 1988: 1177–1183.
[Abstract]
[PDF]
|
|
|
Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma |
| |
F Trave, YM Rustum, NJ Petrelli, L Herrera, A Mittelman, C Frank, and PJ Creaven |
| |
JCO Jul 1 1988: 1184–1191.
[Abstract]
[PDF]
|
|
|
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamide |
| |
SP Ackland, KE Choi, MJ Ratain, MJ Egorin, SF Williams, JA Sinkule, and JD Bitran |
| |
JCO Jul 1 1988: 1192–1196.
[Abstract]
[PDF]
|
|
|
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer |
| |
ET Creagan, RL Richardson, and JS Kovach |
| |
JCO Jul 1 1988: 1197–1201.
[Abstract]
[PDF]
|
|
| Chemotherapy of glomus jugulare tumors |
| RC Shepard, W Lopez, and NJ Robert |
|
JCO Jul 1 1988: 1202a–1204.
[PDF]
|
|
| Elevated beta-2-microglobulin in Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation |
| D Przepiorka |
|
JCO Jul 1 1988: 1202b.
[PDF]
|
|
| Brachial plexopathy after intraarterial cisplatin |
| BL Samuels, CE Kahn, Jr, RN Messersmith, NJ Vogelzang, and MA Simon |
|
JCO Jul 1 1988: 1204a.
[PDF]
|
|
| Acute vasomotor response--a reaction to etoposide |
| AE Athanassiou, D Bafaloukos, D Pectasidis, and M Dimitriadis |
|
JCO Jul 1 1988: 1204b–1205.
[PDF]
|
|
